Our Focus...Initiatives to Move Discoveries to Drugs & Diagnostics (also IMD3)


The Institute for Molecular Diversity and Drug Design (IMD3) was formally approved by the University of Louisville in March, 1999. Current membership consists of 26 faculty members representing eleven units at U of L (Biochemistry & Molecular Biology, Brown Cancer Center, Chemistry, Chemical Engineering, Medicine, Microbiology & Immunology, Pathology & Laboratory Medicine, Periodontology, Pharmacology & Toxicology and Ophthalmology & Visual Sciences.) Principal support for the IMD3 is derived from the College of Arts and Sciences and the Health Sciences Center, and the Director reports to the Executive Vice President for Research.

Recent News: